"Designing Growth Strategies is in our DNA"
Chlamydia is a sexually transmitted disease that is caused due to the bacteria called Chlamydia trachomatis. The symptoms of the chlamydia infections are not seen in the early stages. In fact, about 90.0% of women and 70.0% of men with sexually transmitted diseases have no symptoms. According to Centers for Diseases Control and Prevention (CDC), in 2017, 1,127,651 cases of chlamydia were reported among females at a rate of 687.4 cases per 100,000 females. Multiple infections in females increases the chances of severe complications of the reproductive system, including ectopic pregnancy, and pelvic inflammatory disease.
Current treatment for chlamydia infections includes antibiotics. Food and Drug Administration (FDA) has approved azithromycin (Zithromax) and doxycycline for the treatment of chlamydia infections.
Research Institutes and pharmaceutical companies have focussed on studying and developing new methods for the treatment of chlamydia infections. For instance; CTH522-CAF01, which is being studied by the Statens Serum Institute in collaboration with Imperial College London is currently in phase-1 clinical trials for the study of the safety of chlamydia vaccine CTH522 in healthy women aged 18 to 45 years.
To know how our report can help streamline your business, Speak to Analyst
Currently, more than 50% of the pipeline candidates for chlamydia infections are in phase 2 and phase 3 stage. Majority of the studies have been sponsored by research institutes.
The report on ‘Chlamydia Infections – Pipeline Review, 2019’ provides a comprehensive overview of the drugs that are in the R&D pipeline by indication or molecule for chlamydia infections. The report provides a thorough analysis of the distribution of the pipeline products by clinical trial stage, indication, company, therapy area and details such as clinical trial stage, sponsor, description on every product in the pipeline. Products in the preclinical and clinical stage along with dormant & discontinued pipeline candidates are included in the report. The report also covers additional insights such as epidemiology overview and current market scenario for chlamydia infections.
The report on ‘Chlamydia Infections – Pipeline Review, 2019’, which is built by following a robust research methodology involving primary interviews and desk research, provides a complete overview of the R&D activity and pipeline products to assist companies in developing growth strategies and identifying emerging players.
“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”- One of the Leading Food Companies in Germany
“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”- Intuitive Surgical
“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”- Major Food Company in Japan
“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”- Ziering Medical
“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”- Major Manufacturer of Precision Machine Parts in India
“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”- Hewlett-Packard
“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”- Global Management Consulting Firm
“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”- UK-based Start-up in the Medical Devices Sector
“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”- One of the Largest Companies in the Defence Industry